Acetyl-L-Carnitine (ALCAR): What It Is, Evidence, Dose and Risks

What is ALCAR? Acetyl-L-carnitine is L-carnitine with an acetyl group attached — the form sold for the brain rather than the gym. Its human evidence is strongest in older adults with cognitive decline, in mental fatigue in people over 70, and in diabetic nerve damage, usually at 1.5–3 g a day; for healthy young people the evidence is thin. It is a supplement that feeds two systems from one molecule — fatty-acid transport into mitochondria, and an acetyl group that can feed acetylcholine — which explains its appeal and its two specific cautions, covered below.

Carnitine, ALCAR, and why the acetyl group matters

Plain L-carnitine is a transport molecule. Long-chain fatty acids cannot cross the inner mitochondrial membrane unaided; carnitine carries them in so they can be oxidised for energy. That is a metabolic function, and it is why L-carnitine is sold to athletes and to people with metabolic conditions.

Acetyl-L-carnitine is the same molecule with an acetyl group attached, and it is marketed on the basis that the modification changes what it is useful for: it is described as entering the brain more readily than plain carnitine, and its acetyl group can in principle be used in the synthesis of acetylcholine — a neurotransmitter involved in memory and learning. Both are mechanistic rationales rather than effects measured directly in human brains.

So ALCAR is doing two things simultaneously: supporting mitochondrial fatty-acid oxidation in neurons, and supplying raw material for a neurotransmitter. That is unusual, and it explains why the compound resists being filed under a single category. Our ALCAR ingredient page lists it as an amino acid with a Moderate evidence grade, which reflects a body of human work that is real but uneven.

What the human evidence supports

The strongest ALCAR literature is not in healthy young adults. It is in populations with something to correct. A 2003 meta-analysis (Montgomery et al.) of trials in mild cognitive impairment and mild Alzheimer's disease, at 1.5–3.0 g a day, found a small benefit over placebo (effect size about 0.2). In diabetic neuropathy, two 52-week trials pooled by Sima et al. (2005, Diabetes Care; 1,257 people, 500 mg or 1,000 mg three times daily) reported better nerve-fibre regeneration and vibration perception, with pain improving at the higher dose — but no improvement in nerve conduction velocity. A 2018 meta-analysis (Veronese et al., Psychosomatic Medicine; 12 trials, 791 people) found fewer depressive symptoms with acetyl-L-carnitine than with placebo, though the trials varied widely (I² = 86%), so that result needs cautious reading.

That pattern should look familiar by now. As with creatine and vitamin D, the effect is largest where the system was under strain. In healthy, young, well-nourished people the evidence for a noticeable cognitive lift is much weaker, and honesty requires saying so rather than borrowing the neuropathy results to sell a focus supplement.

There is also a reported effect on mental fatigue in older adults: in 96 people over 70 (Malaguarnera et al., 2008), acetyl-L-carnitine reduced mental fatigue scores compared with placebo. That is the finding that most justifies ALCAR's place in energy-oriented stacks. If your complaint is fatigue rather than distraction, ALCAR and rhodiola approach the same symptom from different directions — mitochondrial supply versus stress-axis regulation.

ALCAR dosage and timing

The trials above used 1.5–3 g a day, usually split into two or three doses; many products sell 500 mg capsules, so a single capsule is below the studied range. There is no good evidence that taking it on an empty stomach matters: carnitine from supplements is absorbed largely passively, and only a minority of the dose reaches the bloodstream either way — the Linus Pauling Institute puts oral bioavailability at 5–25% of the dose.

Many people take it in the morning because some find it mildly activating; if an afternoon dose affects your sleep, move it earlier.

More is not automatically better. The Linus Pauling Institute notes that supplements providing more than 3 g a day may cause a "fishy" body odour, along with nausea, vomiting, abdominal cramps or diarrhoea — the odour comes from gut bacteria breaking carnitine down into trimethylamine.

Which carnitine: ALCAR, L-carnitine or propionyl-L-carnitine

Three carnitines are commonly sold and they are not interchangeable, which the shelf does very little to communicate.

L-carnitine (often as L-carnitine tartrate) is the plain form, usually marketed for exercise recovery and fat metabolism during training. If that is your interest, it is the cheaper and better-matched option, and buying ALCAR for it means paying for a property you do not need.

Acetyl-L-carnitine is the form used in the cognitive-decline, fatigue, neuropathy and mood trials above. If your interest is cognitive, or fatigue you would describe as mental rather than muscular, this is the one the evidence refers to.

Propionyl-L-carnitine is marketed mainly for circulation. It is the least relevant of the three to anything on this site and is included here only so that seeing it on a label does not cause confusion.

Some products combine two or three, which is defensible if you want both the muscular and the cognitive effect, and wasteful if you only want one. As always, check that the label breaks out the amount of each rather than giving a combined "carnitine complex" figure — a blend that does not tell you how much ALCAR it contains cannot be compared against the 1.5–3 g a day the trials used.

One further note on vegetarians and vegans, who come up repeatedly in this series: dietary carnitine, like dietary creatine, comes predominantly from animal foods. The Linus Pauling Institute estimates that omnivorous diets provide about 23–135 mg a day and vegetarian diets about 1 mg — yet the body makes its own carnitine, and it notes that even strict vegans show no signs of carnitine deficiency.

Two cautions that are not boilerplate

Most supplement safety sections are hedging. These two are specific.

Seizure history. Sources disagree here. Some safety references list seizures in people with seizure disorders among the reported effects of carnitine, while the Linus Pauling Institute says claims that L-carnitine or ALCAR increase seizures "are not supported by any scientific evidence". With the evidence that thin in both directions, the sensible course if you have epilepsy or any seizure history is to discuss it with your neurologist rather than trial it privately.

Thyroid medication. Carnitine acts as a peripheral antagonist of thyroid hormone: a study reviewed by Benvenga et al. (2004) describes it inhibiting the entry of T3 and T4 into cell nuclei, and it has been tested at 2–4 g a day to ease symptoms of hyperthyroidism. By the same logic it could, in principle, work against levothyroxine — no study has confirmed that, but it is reason enough not to add it without your prescriber knowing, and not to read a change in how you feel as the supplement working.

The broader framework for weighing this class of risk is in our nootropic safety guide. The short version: a compound with a thyroid-hormone effect and an unsettled seizure question is not one to add casually to an existing prescription.

The TMAO question, in proportion

Gut bacteria metabolise carnitine into trimethylamine, which the liver converts to TMAO — a metabolite associated in observational research with cardiovascular risk. This has generated a lot of alarmed writing about carnitine supplements.

What is fair to say: the human association is observational and the causal picture is disputed. It is not fair to say a capsule is trivial next to diet — a 500 mg capsule is several times the 23–135 mg a day the Linus Pauling Institute estimates an omnivorous diet provides, although much of a supplement dose is never absorbed and it is the unabsorbed carnitine that gut bacteria turn into trimethylamine. What is also fair to say is that we cannot tell you the question is closed, because it is not. If you have established cardiovascular disease, this is worth raising with your cardiologist rather than resolving from a supplement blog — ours included.

Where ALCAR belongs in a stack

ALCAR sits naturally with the mitochondrial compounds — it is one of the three legs alongside the pair covered in our CoQ10 and PQQ comparison, and the three address cellular energy at different points in the same chain. It also pairs with cholinergics: since ALCAR supplies acetyl groups and alpha-GPC or citicoline supply choline, the two halves of acetylcholine synthesis are covered from both sides. Our choline source comparison covers which of those to pick.

On this site ALCAR at 500 mg appears in two protocols — the Executive Performance stack, with citicoline and omega-3, and the Advanced Nootropic stack, where it supplies the acetyl half of noopept's cholinergic demand — and both pages repeat the taxane warning above.

If you would rather buy that combination assembled than build it, Performance Lab's Energy formula lists 500 mg acetyl-L-carnitine per two-capsule serving on its current label, alongside R-lipoic acid, CoQ10 (100 mg) and PQQ (10 mg). Note that 500 mg is below the 1.5–3 g a day used in the trials, so treat it as a combined mitochondrial formula rather than a trial-dose ALCAR product.

See the Performance Lab range and current pricing

Give it four weeks. ALCAR is faster than bacopa and slower than caffeine, and the fatigue outcome it targets is best judged across a working month rather than a single day.

More from The Evidence Files

This piece is part of a ten-part series working through the compounds we hold structured dosing and interaction data for. The companion pieces most relevant here:

• CoQ10 vs PQQ — the other two mitochondrial supports
• Creatine for the brain — cellular energy from the ATP-buffer side
• Rhodiola rosea — fatigue via the stress axis instead

Disclaimer: This content is for informational purposes only and is not medical advice. Statements about supplements have not been evaluated by the Food and Drug Administration, and nothing here is intended to diagnose, treat, cure, or prevent any disease. If you take prescription medication or have a medical condition, consult a qualified healthcare professional before using any supplement. Contains affiliate links — see our disclosure.